FY23. Wastewater-based monitoring of illicit drugs POP 9/1/23 - 8/31/24.

Ended Purchase Order Awarded Last action

Contract number
75N95023P00710
Awardee
Awarding agency
Obligated
$799,971

Award facts

Contract value 100% obligated
$799,971.00 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
Set-aside
No set-aside
Competition
Not Competed · 1 offer Only One Source
Pricing
Firm Fixed Price
Place of performance
Cambridge, MA 02139, USA
Research
SBIR Program Phase III Action
Legislative mandates

Award details come from SAM.gov/FPDS.

Transactions

Action Obligated Date
Funding Only Action P00001 $0
Original award $799,971

About this award

The Department of Health and Human Services (HHS) National Institutes of Health (NIH) National Institute on Drug Abuse awarded a $799,971 firm fixed price purchase order to Biobot Analytics Inc., a self-certified small disadvantaged business, to provide wastewater-based monitoring of illicit drugs from September 1, 2023 through August 31, 2024. This contract is not set aside. Biobot Analytics is a company that specializes in wastewater epidemiology data and analysis, and has previously received federal contracts and grants related to wastewater monitoring for illicit drugs and COVID-19.

Quick answers

Who was awarded contract 75N95023P00710?

75N95023P00710 was awarded to Biobot Analytics Inc. by National Institute on Drug Abuse (National Institutes of Health) on September 1, 2023.

How much is contract 75N95023P00710 worth?

The government has obligated $799,971 on 75N95023P00710.

Was contract 75N95023P00710 competed?

The extent of competition for 75N95023P00710 was not competed. The government received 1 offer.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award